Analyst Ranking
Top 2%
#92 out of 5325 analysts
Average Return
+15.23%
Win Rate
48%247 out of 512
Risk vs Reward
Poor
Good

Douglas Tsao's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+885.37%$33.55$330.59
2025-03-03 -
2026-03-02
Buy
Praxis Precision Medicines IncPRAX
+737.70%$38.06$318.83
2025-05-01 -
2026-04-30
Buy
Praxis Precision Medicines IncPRAX
+544.90%$47.79$308.20
2025-08-05 -
2026-07-16
Buy
Praxis Precision Medicines IncPRAX
+472.33%$53.85$308.20
2025-07-18 -
2026-07-16
Buy
Praxis Precision Medicines IncPRAX
+428.38%$14.55$76.88
2023-11-15 -
2024-11-14
Buy

Douglas Tsao Analyst Color

Get additional color on Douglas Tsao's coverage of popular stocks

Douglas Tsao's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Crinetics Pharmaceuticals IncCRNX
24Hold$85.00+1.30%Downgrades
10 days ago
Theravance Biopharma IncTBPH
17Hold$17.00+0.18%Downgrades
10 days ago
Pacira Biosciences IncPCRX
4Buy$38.00+48.44%Reiterates
16 days ago
Argenx SeARGX
41Buy$940.00+9.56%Reiterates
22 days ago
Neumora Therapeutics IncNMRA
8Buy$7.00+337.50%Maintains
a month ago
Rezolute IncRZLT
20Buy$5.00+14.42%Reiterates
a month ago
Praxis Precision Medicines IncPRAX
34Buy$1,201.00+289.68%Maintains
a month ago
Biohaven LtdBHVN
14Hold$10.00-29.43%Reiterates
2 months ago
Immunovant IncIMVT
24Buy$40.00+2.67%Maintains
2 months ago
Roivant Sciences LtdROIV
25Buy$34.00+0.21%Reiterates
2 months ago
Apellis Pharmaceuticals IncAPLS
29Hold$41.00-0.07%Downgrades
4 months ago
Viridian Therapeutics IncVRDN
17Buy$22.00+22.02%Maintains
4 months ago
Minerva Neurosciences IncNERV
16Hold$7.00+66.27%Maintains
4 months ago
Xenon Pharmaceuticals IncXENE
6Buy$74.00+10.48%Maintains
4 months ago
Arcutis Biotherapeutics IncARQT
5Buy$34.00+22.57%Maintains
5 months ago
Outlook Therapeutics IncOTLK
19Hold$0.50-65.75%Reiterates
5 months ago
Evolus IncEOLS
25Buy$13.00+130.91%Maintains
5 months ago
Protagonist Therapeutics IncPTGX
32Buy$117.00-11.38%Maintains
6 months ago
Rapport Therapeutics IncRAPP
3Buy$40.00-0.32%Maintains
7 months ago
Dare Bioscience IncDARE
18Buy$12.00+518.56%Reiterates
8 months ago
Cabaletta Bio IncCABA
26Buy$16.00+499.25%Reiterates
9 months ago
Alkermes PLCALKS
17Hold$46.00-11.44%Reiterates
10 months ago
EVO
10Buy$7.00-23.16%Maintains
a year ago
Disc Medicine IncIRON
16Buy$118.00N/AReiterates
a year ago
Sage Therapeutics IncSAGE
21Hold$12.00N/AReiterates
a year ago
Coherus Oncology IncCHRS
25Buy$7.00N/AReiterates
a year ago
Scpharmaceuticals IncSCPH
14Buy$18.00N/AReiterates
a year ago
Trevena IncTRVN
9Hold$5.00N/ADowngrades
2 years ago
Marinus Pharmaceuticals IncMRNS
18Hold$2.00N/AReiterates
2 years ago
Revance Therapeutics IncRVNC
18Hold$6.60N/AReiterates
2 years ago
Aeon Biopharma IncAEON
8Buy$360.00N/AReiterates
2 years ago
Cerevel Therapeutics Holdings IncCERE
6Hold$45.00N/ADowngrades
3 years ago
Rvl Pharmaceuticals PLCRVLPQ
3Buy$3.00N/AMaintains
3 years ago
Climb Bio IncCLYM
2Hold$6.00N/AReiterates
3 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$74.00N/AInitiates Coverage On
4 years ago
Therapeuticsmd IncTXMD
5Hold$10.00N/ADowngrades
4 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
4HoldN/AN/ADowngrades
4 years ago
Histogen IncHSTOQ
2Buy$30.00N/AMaintains
4 years ago
Amryt Pharma PLCAMYT
2Buy$18.00N/AMaintains
4 years ago
Radius Health IncRDUS1
5Hold$10.00N/AMaintains
5 years ago
Gw Pharmaceuticals PLCGWPH
3Hold$220.00N/ADowngrades
5 years ago
Amag Pharmaceuticals IncAMAG
2Hold$13.75N/ADowngrades
6 years ago
Momenta Pharmaceuticals IncMNTA
4Hold$52.50N/ADowngrades
6 years ago
Chiasma IncCHMA
2Buy$10.00N/AMaintains
6 years ago
Dermira IncDERM2
1Hold$18.75N/ADowngrades
6 years ago
Icon PLCICLR
3Hold$148.00N/AMaintains
7 years ago
Teva Pharmaceutical Industries LtdTEVA
5Hold$23.00N/AMaintains
8 years ago
Phibro Animal Health CorpPAHC
1Strong Sell$33.00N/AMaintains
8 years ago
Pfenex IncPFNX
1Strong Buy$8.00N/AMaintains
8 years ago
Endo International PLCENDPQ
1Hold$10.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.